{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T18:18:58Z","timestamp":1790533138177,"version":"4.1.0"},"reference-count":131,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.dld.2020.05.034","type":"journal-article","created":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T13:46:55Z","timestamp":1592056015000},"page":"26-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Increased risk of acute liver failure by pain killer drugs in NAFLD: Focus on nuclear receptors and their coactivators"],"prefix":"10.1016","volume":"53","author":[{"given":"Maria","family":"Arconzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Piccinin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Moschetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.dld.2020.05.034_bib0001","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1016\/j.jhep.2008.01.009","article-title":"Non-alcoholic fatty liver disease: the mist gradually clears","volume":"48","author":"de Alwis","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2020.05.034_bib0002","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease - a global public health perspective","volume":"70","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2020.05.034_bib0003","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/TP.0000000000002484","article-title":"Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: implications for liver transplantation","volume":"103","author":"Younossi","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.dld.2020.05.034_bib0004","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jhep.2010.04.008","article-title":"A position statement on NAFLD\/NASH based on the EASL 2009 special conference","volume":"53","author":"Ratziu","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2020.05.034_bib0005","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.dld.2020.05.034_bib0006","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/apt.12046","article-title":"Review article: is non-alcoholic fatty liver disease a spectrum, or are steatosis and non-alcoholic steatohepatitis distinct conditions?","volume":"36","author":"Yilmaz","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2020.05.034_bib0007","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/343828","article-title":"Noninvasive assessment of fibrosis in patients with nonalcoholic fatty liver disease","volume":"2015","author":"Buzzetti","year":"2015","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.dld.2020.05.034_bib0008","doi-asserted-by":"crossref","first-page":"20704","DOI":"10.3390\/ijms141020704","article-title":"Multiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH)","volume":"14","author":"Takaki","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.dld.2020.05.034_bib0009","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s00535-006-1790-5","article-title":"Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease","volume":"41","author":"Eguchi","year":"2006","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.dld.2020.05.034_bib0010","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: a tale of two \"hits\"?","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2020.05.034_bib0011","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/ncpendmet0190","article-title":"Mechanisms of disease: hepatic steatosis in type 2 diabetes\u2013pathogenesis and clinical relevance","volume":"2","author":"Roden","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/j.dld.2020.05.034_bib0012","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0168-8278(96)80030-4","article-title":"Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in mice","volume":"24","author":"Letteron","year":"1996","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2020.05.034_bib0013","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1053\/gast.1996.v110.pm8964414","article-title":"Uncoupling of rat and human mitochondria: a possible explanation for tacrine-induced liver dysfunction","volume":"110","author":"Berson","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2020.05.034_bib0014","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.1204265","article-title":"Human fatty liver disease: old questions and new insights","volume":"332","author":"Cohen","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.dld.2020.05.034_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mito.2005.10.004","article-title":"Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it","volume":"6","author":"Begriche","year":"2006","journal-title":"Mitochondrion"},{"key":"10.1016\/j.dld.2020.05.034_bib0016","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1172\/JCI82204","article-title":"Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver","volume":"125","author":"Satapati","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.dld.2020.05.034_bib0017","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9547613","article-title":"Role of oxidative stress in pathophysiology of nonalcoholic fatty liver disease","volume":"2018","author":"Masarone","year":"2018","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.dld.2020.05.034_bib0018","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.clinbiochem.2012.03.024","article-title":"Role of mitochondria in nonalcoholic fatty liver disease\u2013from origin to propagation","volume":"45","author":"Grattagliano","year":"2012","journal-title":"Clin Biochem"},{"key":"10.1016\/j.dld.2020.05.034_bib0019","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.tplants.2011.03.007","article-title":"ROS signaling: the new wave?","volume":"16","author":"Mittler","year":"2011","journal-title":"Trends Plant Sci"},{"key":"10.1016\/j.dld.2020.05.034_bib0020","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jhep.2012.08.018","article-title":"CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease","volume":"58","author":"Leung","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2020.05.034_bib0021","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1042\/CS20070461","article-title":"Is adipose tissue lipolysis always an adaptive response to starvation?: implications for non-alcoholic fatty liver disease","volume":"114","author":"Gan","year":"2008","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.dld.2020.05.034_bib0022","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2020.05.034_bib0023","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev-pathol-121808-102132","article-title":"Nonalcoholic fatty liver disease: pathology and pathogenesis","volume":"5","author":"Tiniakos","year":"2010","journal-title":"Ann Rev Pathol"},{"key":"10.1016\/j.dld.2020.05.034_bib0024","doi-asserted-by":"crossref","first-page":"8591","DOI":"10.3390\/ijms15058591","article-title":"Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation","volume":"15","author":"Peverill","year":"2014","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.dld.2020.05.034_bib0025","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/carcin\/bgx007","article-title":"Microbiota, NASH, HCC and the potential role of probiotics","volume":"38","author":"Brandi","year":"2017","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.dld.2020.05.034_bib0026","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.3349\/ymj.2017.58.6.1083","article-title":"Alterations in gut microbiota and immunity by dietary fat","volume":"58","author":"Yang","year":"2017","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.dld.2020.05.034_bib0027","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/hep.22848","article-title":"Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease","volume":"49","author":"Miele","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2020.05.034_bib0028","article-title":"Obesogenic diet-induced gut barrier dysfunction and pathobiont expansion aggravate experimental colitis","volume":"12","author":"Lee","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.dld.2020.05.034_bib0029","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jcmgh.2015.01.001","article-title":"Hepatic injury in nonalcoholic steatohepatitis contributes to altered intestinal permeability","volume":"1","author":"Luther","year":"2015","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2020.05.034_bib0030","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.26494","article-title":"Microbiota-liver axis in hepatic disease","volume":"59","author":"Chassaing","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2020.05.034_bib0031","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.4254\/wjh.v7.i15.1905","article-title":"Cross talk of the immune system in the adipose tissue and the liver in non-alcoholic steatohepatitis: pathology and beyond","volume":"7","author":"Vonghia","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.dld.2020.05.034_bib0032","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3389\/fendo.2018.00485","article-title":"Pathogenesis of nonalcoholic steatohepatitis and hormone-based therapeutic approaches","volume":"9","author":"Kim","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.dld.2020.05.034_bib0033","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1136\/gutjnl-2016-313654","article-title":"Adipose tissue macrophages induce hepatic neutrophil recruitment and macrophage accumulation in mice","volume":"67","author":"Bijnen","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.dld.2020.05.034_bib0034","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0140-6736(19)31894-X","article-title":"Acute liver failure","volume":"394","author":"Stravitz","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2020.05.034_bib0035","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s12185-015-1820-2","article-title":"Clinical usefulness of international normalized ratio calibration of prothrombin time in patients with chronic liver disease","volume":"102","author":"Lee","year":"2015","journal-title":"Int J Hematol"},{"key":"10.1016\/j.dld.2020.05.034_bib0036","doi-asserted-by":"crossref","first-page":"412","DOI":"10.4254\/wjh.v11.i5.412","article-title":"Roles of hepatic stellate cells in acute liver failure: from the perspective of inflammation and fibrosis","volume":"11","author":"Li","year":"2019","journal-title":"World J Hepatol"},{"key":"10.1016\/j.dld.2020.05.034_bib0037","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0140-6736(10)60274-7","article-title":"Acute liver failure","volume":"376","author":"Bernal","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2020.05.034_bib0038","doi-asserted-by":"crossref","first-page":"830","DOI":"10.2174\/1389200219666180523095355","article-title":"Models of Drug Induced Liver Injury (DILI) - Current Issues and Future Perspectives","volume":"19","author":"Kuna","year":"2018","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.dld.2020.05.034_bib0039","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.tips.2013.01.009","article-title":"Regulation of drug-induced liver injury by signal transduction pathways: critical role of mitochondria","volume":"34","author":"Han","year":"2013","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.dld.2020.05.034_bib0040","first-page":"73","article-title":"Drug-induced liver injury","volume":"6","author":"David","year":"2010","journal-title":"US Gastroenterol Hepatol Rev"},{"key":"10.1016\/j.dld.2020.05.034_bib0041","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1084\/jem.185.8.1481","article-title":"Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis","volume":"185","author":"Leist","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.dld.2020.05.034_bib0042","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/toxsci\/59.1.169","article-title":"High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes","volume":"59","author":"Enomoto","year":"2001","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.dld.2020.05.034_bib0043","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1002\/hep.23937","article-title":"Drug-induced acute liver failure: results of a U.S. multicenter, prospective study","volume":"52","author":"Reuben","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2020.05.034_bib0044","first-page":"29","article-title":"Ticlopidine-induced hepatotoxicity is associated with specific human leukocyte antigen genomic subtypes in Japanese patients: a preliminary case-control study","volume":"8","author":"Hirata","year":"2008","journal-title":"Pharm J"},{"key":"10.1016\/j.dld.2020.05.034_bib0045","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/168905","article-title":"Drug induced steatohepatitis: an uncommon culprit of a common disease","volume":"2015","author":"Rabinowich","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.dld.2020.05.034_bib0046","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1136\/bmj.38391.663287.E0","article-title":"Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial","volume":"330","author":"Bruno","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.dld.2020.05.034_bib0047","doi-asserted-by":"crossref","first-page":"947","DOI":"10.7326\/0003-4819-137-12-200212170-00007","article-title":"Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States","volume":"137","author":"Ostapowicz","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.dld.2020.05.034_bib0048","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1046\/j.0306-5251.2001.01476.x","article-title":"Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies","volume":"52","author":"Garcia Rodriguez","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.dld.2020.05.034_bib0049","first-page":"95","article-title":"Hepatotoxicity of paracetamol and related fatalities","volume":"21","author":"Tittarelli","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.dld.2020.05.034_bib0050","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/hep.26294","article-title":"Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital","volume":"58","author":"Antoine","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2020.05.034_bib0051","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1007\/s11095-013-1007-6","article-title":"Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis","volume":"30","author":"McGill","year":"2013","journal-title":"Pharm Res"},{"key":"10.1016\/j.dld.2020.05.034_bib0052","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/j.gastro.2006.03.045","article-title":"c-Jun N-terminal kinase plays a major role in murine acetaminophen hepatotoxicity","volume":"131","author":"Gunawan","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2020.05.034_bib0053","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1053\/j.gastro.2012.06.004","article-title":"A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches","volume":"143","author":"Seki","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2020.05.034_bib0054","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1478-3231.2011.02501.x","article-title":"Acetaminophen hepatotoxicity and repair: the role of sterile inflammation and innate immunity","volume":"32","author":"Jaeschke","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2020.05.034_bib0055","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/978-3-642-00663-0_10","article-title":"Signal transduction pathways involved in drug-induced liver injury","author":"Han","year":"2010","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.dld.2020.05.034_bib0056","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/978-3-642-00663-0_12","article-title":"Mechanisms of acetaminophen-induced liver necrosis","author":"Hinson","year":"2010","journal-title":"Handb Exp Pharmacol"},{"issue":"Suppl 1","key":"10.1016\/j.dld.2020.05.034_bib0057","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11739-011-0688-2","article-title":"Management of patients with chronic kidney disease","volume":"6","author":"Schena","year":"2011","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.dld.2020.05.034_bib0058","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1440-1746.1992.tb00926.x","article-title":"Significance of plasma glutathione determination in patients with alcoholic and non-alcoholic liver disease","volume":"7","author":"Shigesawa","year":"1992","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2020.05.034_bib0059","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/hep.22536","article-title":"Hepatitis C is a predictor of acute liver injury among hospitalizations for acetaminophen overdose in the United States: a nationwide analysis","volume":"48","author":"Nguyen","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2020.05.034_bib0060","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1136\/gut.29.9.1153","article-title":"Glutathione deficiency in alcoholics: risk factor for paracetamol hepatotoxicity","volume":"29","author":"Lauterburg","year":"1988","journal-title":"Gut"},{"key":"10.1016\/j.dld.2020.05.034_bib0061","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1053\/jhep.2002.32148","article-title":"Acute versus chronic alcohol consumption in acetaminophen-induced hepatotoxicity","volume":"35","author":"Schmidt","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2020.05.034_bib0062","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1001\/jama.1994.03520230055038","article-title":"Association of acetaminophen hepatotoxicity with fasting and ethanol use","volume":"272","author":"Whitcomb","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.dld.2020.05.034_bib0063","doi-asserted-by":"crossref","first-page":"c6764","DOI":"10.1136\/bmj.c6764","article-title":"Acute liver failure after administration of paracetamol at the maximum recommended daily dose in adults","volume":"341","author":"Claridge","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.dld.2020.05.034_bib0064","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0022-5347(25)00230-7","article-title":"Obesity as a risk factor in drug-induced organ injury: increased liver and kidney damage by acetaminophen in the obese overfed rat","volume":"241","author":"Corcoran","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.dld.2020.05.034_bib0065","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1440-1746.2011.06807.x","article-title":"Susceptibility of rat non-alcoholic fatty liver to the acute toxic effect of acetaminophen","volume":"27","author":"Kucera","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"issue":"Suppl 2","key":"10.1016\/j.dld.2020.05.034_bib0066","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.33549\/physiolres.932395","article-title":"Steatotic rat hepatocytes in primary culture are more susceptible to the acute toxic effect of acetaminophen","volume":"61","author":"Kucera","year":"2012","journal-title":"Physiol Res"},{"key":"10.1016\/j.dld.2020.05.034_bib0067","doi-asserted-by":"crossref","first-page":"916","DOI":"10.15252\/msb.20167422","article-title":"Personal model-assisted identification of NAD(+) and glutathione metabolism as intervention target in NAFLD","volume":"13","author":"Mardinoglu","year":"2017","journal-title":"Mol Syst Biol"},{"key":"10.1016\/j.dld.2020.05.034_bib0068","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2003.50095","article-title":"Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis","volume":"37","author":"Chalasani","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2020.05.034_bib0069","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.clinre.2011.04.015","article-title":"Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role","volume":"35","author":"Aubert","year":"2011","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.dld.2020.05.034_bib0070","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/10739680500383423","article-title":"Dietary steatotic liver attenuates acetaminophen hepatotoxicity in mice","volume":"13","author":"I to","year":"2006","journal-title":"Microcirculation"},{"key":"10.1016\/j.dld.2020.05.034_bib0071","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12876-017-0680-z","article-title":"Fast food diet-induced non-alcoholic fatty liver disease exerts early protective effect against acetaminophen intoxication in mice","volume":"17","author":"Kim","year":"2017","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.dld.2020.05.034_bib0072","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1038\/oby.2008.337","article-title":"Beta-aminoisobutyric acid prevents diet-induced obesity in mice with partial leptin deficiency","volume":"16","author":"Begriche","year":"2008","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.dld.2020.05.034_bib0073","doi-asserted-by":"crossref","first-page":"E834","DOI":"10.1152\/ajpendo.00332.2001","article-title":"Heterogeneous metabolic adaptation of C57BL\/6 J mice to high-fat diet","volume":"282","author":"Burcelin","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.dld.2020.05.034_bib0074","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1002\/hep.22828","article-title":"Pioglitazone promotes survival and prevents hepatic regeneration failure after partial hepatectomy in obese and diabetic KK-A(y) mice","volume":"49","author":"Aoyama","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2020.05.034_bib0075","doi-asserted-by":"crossref","first-page":"8878","DOI":"10.1073\/pnas.94.16.8878","article-title":"Physiological response to long-term peripheral and central leptin infusion in lean and obese mice","volume":"94","author":"Halaas","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.dld.2020.05.034_bib0076","doi-asserted-by":"crossref","first-page":"G329","DOI":"10.1152\/ajpgi.00361.2009","article-title":"Diabetic KK-A(y) mice are highly susceptible to oxidative hepatocellular damage induced by acetaminophen","volume":"299","author":"Kon","year":"2010","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.dld.2020.05.034_bib0077","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1124\/jpet.112.193813","article-title":"Differences in early acetaminophen hepatotoxicity between obese ob\/ob and db\/db mice","volume":"342","author":"Aubert","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.dld.2020.05.034_bib0078","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0168-8278(03)00460-4","article-title":"Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice","volume":"39","author":"Feldstein","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2020.05.034_bib0079","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.bbalip.2010.04.010","article-title":"Lipid-induced up-regulation of human acyl-CoA synthetase 5 promotes hepatocellular apoptosis","volume":"1801","author":"Reinartz","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.dld.2020.05.034_bib0080","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1053\/j.gastro.2016.01.025","article-title":"Inflammation in alcoholic and nonalcoholic fatty liver disease: friend or foe?","volume":"150","author":"Gao","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2020.05.034_bib0081","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.3748\/wjg.v16.i38.4773","article-title":"Hepatic steatosis, low-grade chronic inflammation and hormone\/growth factor\/adipokine imbalance","volume":"16","author":"Tarantino","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2020.05.034_bib0082","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1530\/JOE-13-0201","article-title":"Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance","volume":"218","author":"Asrih","year":"2013","journal-title":"J Endocrinol"},{"key":"10.1016\/j.dld.2020.05.034_bib0083","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.102.041624","article-title":"Inflammation and drug idiosyncrasy\u2013is there a connection?","volume":"307","author":"Roth","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.dld.2020.05.034_bib0084","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/hep.24552","article-title":"Nuclear factor high-mobility group box1 mediating the activation of Toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice","volume":"54","author":"Li","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2020.05.034_bib0085","doi-asserted-by":"crossref","first-page":"5971","DOI":"10.1038\/s41598-019-42564-5","article-title":"HMGB1 is a central driver of dynamic pro-inflammatory networks in pediatric acute liver failure induced by acetaminophen","volume":"9","author":"Zamora","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.dld.2020.05.034_bib0086","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI76887","article-title":"The HMGB1\/RAGE axis triggers neutrophil-mediated injury amplification following necrosis","volume":"125","author":"Huebener","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.dld.2020.05.034_bib0087","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4103\/2231-4040.90879","article-title":"The peroxisome proliferator-activated receptor: a family of nuclear receptors role in various diseases","volume":"2","author":"Tyagi","year":"2011","journal-title":"J Adv Pharm Technol Res"},{"key":"10.1016\/j.dld.2020.05.034_bib0088","article-title":"Insights into the Role of PPARbeta\/delta in NAFLD","volume":"19","author":"Chen","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.dld.2020.05.034_bib0089","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1210\/en.2005-1132","article-title":"Peroxisome proliferator-activated receptor alpha mediates the effects of high-fat diet on hepatic gene expression","volume":"147","author":"Patsouris","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.dld.2020.05.034_bib0090","doi-asserted-by":"crossref","first-page":"E703","DOI":"10.1152\/ajpendo.00072.2001","article-title":"Diet-induced obesity and hepatic gene expression alterations in C57BL\/6 J and ICAM-1-deficient mice","volume":"282","author":"Gregoire","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.dld.2020.05.034_bib0091","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1053\/meta.2001.26759","article-title":"Exposure to an obesity-inducing diet early affects the pattern of expression of peroxisome proliferator, retinoic acid, and triiodothyronine nuclear receptors in the rat","volume":"50","author":"Redonnet","year":"2001","journal-title":"Metabolism"},{"key":"10.1016\/j.dld.2020.05.034_bib0092","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3945\/jn.110.135210","article-title":"PPARalpha expression protects male mice from high fat-induced nonalcoholic fatty liver","volume":"141","author":"Abdelmegeed","year":"2011","journal-title":"J Nutr"},{"key":"10.1016\/j.dld.2020.05.034_bib0093","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/jhep.2003.50307","article-title":"Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice","volume":"38","author":"Ip","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2020.05.034_bib0094","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1006\/faat.1996.0026","article-title":"Protection against acetaminophen hepatotoxicity by a single dose of clofibrate: effects on selective protein arylation and glutathione depletion","volume":"29","author":"Manautou","year":"1996","journal-title":"Fundam Appl Toxicol"},{"key":"10.1016\/j.dld.2020.05.034_bib0095","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/toxsci\/57.2.338","article-title":"Peroxisome proliferator-activated receptor alpha-null mice lack resistance to acetaminophen hepatotoxicity following clofibrate exposure","volume":"57","author":"Chen","year":"2000","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.dld.2020.05.034_bib0096","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/hep.25645","article-title":"Peroxisome proliferator-activated receptor alpha induction of uncoupling protein 2 protects against acetaminophen-induced liver toxicity","volume":"56","author":"Patterson","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2020.05.034_bib0097","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1021\/tx800464q","article-title":"Serum metabolomics reveals irreversible inhibition of fatty acid beta-oxidation through the suppression of PPARalpha activation as a contributing mechanism of acetaminophen-induced hepatotoxicity","volume":"22","author":"Chen","year":"2009","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.dld.2020.05.034_bib0098","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.bbadis.2016.02.001","article-title":"Enhanced hepatotoxicity by acetaminophen in Vanin-1 knockout mice is associated with deficient proliferative and immune responses","volume":"1862","author":"Ferreira","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.dld.2020.05.034_bib0099","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1096\/fj.02-1186fje","article-title":"Activation of PPAR-alpha in streptozotocin-induced diabetes is essential for resistance against acetaminophen toxicity","volume":"17","author":"Shankar","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.dld.2020.05.034_bib0100","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3389\/fphar.2017.00705","article-title":"Acetaminophen-Induced Liver Injury Alters the Acyl Ethanolamine-Based Anti-Inflammatory Signaling System in Liver","volume":"8","author":"Rivera","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.dld.2020.05.034_bib0101","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/cvr\/cvq076","article-title":"The nuclear factor-kappaB-interleukin-6 signalling pathway mediating vascular inflammation","volume":"86","author":"Brasier","year":"2010","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.dld.2020.05.034_bib0102","doi-asserted-by":"crossref","first-page":"5308","DOI":"10.1093\/nar\/gki836","article-title":"NF-kappaB controls the global pro-inflammatory response in endothelial cells: evidence for the regulation of a pro-atherogenic program","volume":"33","author":"Kempe","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.dld.2020.05.034_bib0103","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.taap.2008.02.031","article-title":"Nonalcoholic steatohepatitic (NASH) mice are protected from higher hepatotoxicity of acetaminophen upon induction of PPARalpha with clofibrate","volume":"230","author":"Donthamsetty","year":"2008","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.dld.2020.05.034_bib0104","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.freeradbiomed.2009.06.017","article-title":"Role of peroxisome proliferator-activated receptor-alpha in fasting-mediated oxidative stress","volume":"47","author":"Abdelmegeed","year":"2009","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.dld.2020.05.034_bib0105","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.bbrc.2004.09.110","article-title":"PPARalpha ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats","volume":"324","author":"Toyama","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.dld.2020.05.034_bib0106","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1742-4658.2005.05060.x","article-title":"Peroxisome proliferator-activated receptor alpha plays a vital role in inducing a detoxification system against plant compounds with crosstalk with other xenobiotic nuclear receptors","volume":"273","author":"Motojima","year":"2006","journal-title":"FEBS J"},{"key":"10.1016\/j.dld.2020.05.034_bib0107","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1386-6346(00)00089-9","article-title":"Regulation of peroxisome proliferator activated receptor alpha-mediated pathways in alcohol fed cytochrome P450 2E1 deficient mice","volume":"19","author":"Wan","year":"2001","journal-title":"Hepatol Res"},{"key":"10.1016\/j.dld.2020.05.034_bib0108","doi-asserted-by":"crossref","first-page":"G403","DOI":"10.1152\/ajpgi.00154.2014","article-title":"Increased 4-hydroxynonenal protein adducts in male GSTA4-4\/PPAR-alpha double knockout mice enhance injury during early stages of alcoholic liver disease","volume":"308","author":"Ronis","year":"2015","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.dld.2020.05.034_bib0109","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41575-018-0089-3","article-title":"Metabolic aspects in NAFLD, NASH and hepatocellular carcinoma: the role of PGC1 coactivators","volume":"16","author":"Piccinin","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2020.05.034_bib0110","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/hep.26222","article-title":"Hepatic-specific activation of peroxisome proliferator-activated receptor gamma coactivator-1beta protects against steatohepatitis","volume":"57","author":"Bellafante","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2020.05.034_bib0111","doi-asserted-by":"crossref","first-page":"16821","DOI":"10.1038\/s41598-019-53015-6","article-title":"PGC-1beta induces susceptibility to acetaminophen-driven acute liver failure","volume":"9","author":"Piccinin","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.dld.2020.05.034_bib0112","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/hep.27060","article-title":"Fibroblast growth factor 21 protects against acetaminophen-induced hepatotoxicity by potentiating peroxisome proliferator-activated receptor coactivator protein-1alpha-mediated antioxidant capacity in mice","volume":"60","author":"Ye","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2020.05.034_bib0113","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.fct.2017.08.020","article-title":"Induction of mitochondrial biogenesis protects against acetaminophen hepatotoxicity","volume":"108","author":"Du","year":"2017","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.dld.2020.05.034_bib0114","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.freeradbiomed.2004.11.012","article-title":"Mechanisms of glutamate cysteine ligase (GCL) induction by 4-hydroxynonenal","volume":"38","author":"Iles","year":"2005","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.dld.2020.05.034_bib0115","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1161\/ATVBAHA.107.155739","article-title":"Hepatic PGC-1beta overexpression induces combined hyperlipidemia and modulates the response to PPARalpha activation","volume":"27","author":"Lelliott","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.dld.2020.05.034_bib0116","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cell.2004.11.043","article-title":"Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP","volume":"120","author":"Lin","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.dld.2020.05.034_bib0117","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","article-title":"Molecular mechanism of PPARalpha action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease","volume":"62","author":"Pawlak","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2020.05.034_bib0118","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.2337\/dc11-0093","article-title":"Effects of the new dual PPAR alpha\/delta agonist GFT505 on lipid and glucose homeostasis in abdominally obese patients with combined dyslipidemia or impaired glucose metabolism","volume":"34","author":"Cariou","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dld.2020.05.034_bib0119","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1475-2840-12-82","article-title":"Selective peroxisome proliferator-activated receptor alpha modulators (SPPARMalpha): the next generation of peroxisome proliferator-activated receptor alpha-agonists","volume":"12","author":"Fruchart","year":"2013","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.dld.2020.05.034_bib0120","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1136\/bmj.2.6198.1097","article-title":"Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning","volume":"2","author":"Prescott","year":"1979","journal-title":"Br Med J"},{"key":"10.1016\/j.dld.2020.05.034_bib0121","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0140-6736(77)90612-2","article-title":"Treatment of paracetamol (acetaminophen) poisoning with N-acetylcysteine","volume":"2","author":"Prescott","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2020.05.034_bib0122","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1056\/NEJMct0708278","article-title":"Acetylcysteine for acetaminophen poisoning","volume":"359","author":"Heard","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2020.05.034_bib0123","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1172\/JCI110853","article-title":"Mechanism of action of N-acetylcysteine in the protection against the hepatotoxicity of acetaminophen in rats in vivo","volume":"71","author":"Lauterburg","year":"1983","journal-title":"J Clin Invest"},{"key":"10.1016\/j.dld.2020.05.034_bib0124","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1073\/pnas.81.5.1327","article-title":"N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen","volume":"81","author":"Dahlin","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.dld.2020.05.034_bib0125","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-3565(25)25048-0","article-title":"Role of glutathione in prevention of acetaminophen-induced hepatotoxicity by N-acetyl-l-cysteine in vivo: studies with N-acetyl-d-cysteine in mice","volume":"238","author":"Corcoran","year":"1986","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.dld.2020.05.034_bib0126","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/hep.23267","article-title":"Novel mechanisms of protection against acetaminophen hepatotoxicity in mice by glutathione and N-acetylcysteine","volume":"51","author":"Saito","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2020.05.034_bib0127","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/jbt.20042","article-title":"Diverse antioxidants protect against acetaminophen hepatotoxicity","volume":"18","author":"Oz","year":"2004","journal-title":"J Biochem Mol Toxicol"},{"key":"10.1016\/j.dld.2020.05.034_bib0128","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.jfda.2017.11.004","article-title":"Association of antioxidant nutraceuticals and acetaminophen (paracetamol): friend or foe?","volume":"26","author":"Abdel-Daim","year":"2018","journal-title":"J Food Drug Anal"},{"key":"10.1016\/j.dld.2020.05.034_bib0129","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.fct.2012.01.027","article-title":"Green tea extract can potentiate acetaminophen-induced hepatotoxicity in mice","volume":"50","author":"Salminen","year":"2012","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.dld.2020.05.034_bib0130","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1124\/dmd.111.039149","article-title":"UGT1A6 and UGT2B15 polymorphisms and acetaminophen conjugation in response to a randomized, controlled diet of select fruits and vegetables","volume":"39","author":"Navarro","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dld.2020.05.034_bib0131","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1056\/NEJMra1208937","article-title":"Acute liver failure","volume":"369","author":"Bernal","year":"2013","journal-title":"N Engl J Med"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865820302371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865820302371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:14:04Z","timestamp":1761624844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865820302371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":131,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1590865820302371"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2020.05.034","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased risk of acute liver failure by pain killer drugs in NAFLD: Focus on nuclear receptors and their coactivators","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2020.05.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}